EMN Options Turn Bullish Ahead of Q3 Rerun
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Eastman Chemical reports again on November 5, just six days after posting its October 30 print, which landed with a 1.7% decline in the shares.
The most striking shift since that print is in options positioning. Call demand has surged relative to puts, pushing the put/call ratio to 0.29, more than 2.6 standard deviations below its 20-day average of 0.45. That is close to the most call-heavy reading of the past year, against a 52-week low of 0.17. The move represents a sharp reversal from the defensive tone that dominated options flow through most of October, when the ratio held steadily above 0.44. Lending conditions remain loose: availability of shares to borrow is extremely wide, providing no squeeze pressure on the short side.
Short interest sits at 5.4% of the free float, roughly steady week-on-week after a 5.5% weekly decline. The position has edged up about 10.5% over the past month, so there is a meaningful short base in place, but the borrow cost of 0.51% is low and availability is ample. That combination points to short sellers who are comfortable holding, not scrambling.
The analyst debate has tightened rather than resolved since the last preview. Barclays raised its target by $2 to $74 on November 2, maintaining Equal-Weight. JP Morgan on the same day trimmed its target by $1 to $65, also holding Neutral. That leaves the two most recently active bellwether views straddling the current price of $66.78, with the consensus mean at $74.81 implying roughly 12% upside. The bull case rests on Eastman's specialty mix, now around 70% of the portfolio, and on pricing improvement in Additives and Advanced Materials. The bear case focuses on a still-depressed multiple versus peers, lingering Tow demand weakness in Europe, and the Q3 guidance cut that preceded the October print. Eastman's earnings yield ranks in the 82nd percentile of the ORTEX universe, a valuation argument that bulls lean on; the PE of around 10x is undemanding for a business this far through a specialty transition.
Institutional ownership is concentrated: BlackRock holds nearly 15% of shares and added to its position in Q3, while Dimensional Fund Advisors added roughly 227,000 shares in the same period. The most recent open-market insider transaction was a $234,000 sale by the Chief HR Officer in August, small in the context of the company and not directionally notable.
The November 5 print tests whether the Q3 result and any forward guidance can close the gap between where the Street's cautious majority has anchored its targets and the more optimistic options positioning that has emerged in the days since.
Stocks in this article
See the live data behind this article on ORTEX.
Open EMN on ORTEX →How this article was generated
- Generated
- 3 Nov 2026, 05:24
- Data as of
- 3 Nov 2026, 04:22
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.